TwitterFacebookGoogle+LinkedInPinterest

Featured Posts



Henry Ford Health System Launches Project To Help Patients Have “The Conversation” About End-of-Life Care

Henry Ford Health System is embarking on a major initiative over the coming year to inform its patients about “The Conversation” – an often daunting and uncomfortable discussion of advance planning for death and dying.

logo_homeThe initiative is part of an ongoing nationwide project aimed at helping individuals and families prepare for a loved one’s final wishes before fatal disease or dying forces the issue under stress and emotional strain.

The Conversation” is meant to take place even before the drafting of an advance directive that legally spells out what health care actions and limits an individual wants if he or she is unable to make decisions because of incapacity, serious illness or death.

National DNA Day Is April 25; Experts Available For Comment

Friday, April 25, is National DNA Day, the date which commemorates completion of the Human Genome Project, the national effort to identify and decode all 6 billion letters in human DNA. Since that time, medical researchers and practitioners have found new ways to apply genomics for everyone who needs healing, and thanks to staggering technological advancements and next-generation sequencing, the cost to sequence a patient’s genome has decreased from $3 billion for the first human genome in 2003 to approximately $1,500.

Recommendations For Managing Critical National Shortage Of IV Solutions Released

A new set of recommendations to help healthcare providers deal with ongoing and acute national shortages of certain large-volume intravenous (IV) solutions, developed by the American Society of Health-System Pharmacists (ASHP) in partnership with the University of Utah Drug Information Service, was released today by ASHP and the University, as well as the American Hospital Association and other stakeholders.

logo_ashpA national shortage of large-volume (i.e., 1,000 mL) IV solutions (including 0.9% and 0.45% sodium chloride injection, lactated Ringer’s injection, and 5% dextrose injection) has affected many hospitals and other healthcare sites nationwide. The shortages, which are a result of an unusual spike in demand, are not expected to resolve until May or June 2014.

“The national shortage of IV solutions is a challenging patient care issue that many of our members are having to manage on a daily basis,” said Paul W. Abramowitz, PharmD, ScD (Hon.), FASHP, ASHP chief executive officer. “We felt it was critical to provide practical and easy-to-implement strategies to help healthcare providers navigate this crisis and ensure that their patients continue to receive the best care possible.”

Study Shows Myofascial Roller Massage Reduces Delayed Onset Muscle Soreness

A recently published study in The International Journal of Sports Physical Therapy demonstrated the effectiveness of an inexpensive, easy-to-use massage tool on reducing hamstring muscle soreness after high intensity exercise. The study, conducted at the National Research Centre for the Working Environment in Copenhagen, Denmark, investigated the acute effect of massage with the TheraBand™ Roller Massager+ on delayed onset muscle soreness (DOMS).

DOMS, often observed in athletes, is a common consequence of unaccustomed exercise or overtraining especially with the inclusion of extensive eccentric contractions. The presence of DOMS inhibits muscle activity or motor performance for up to several days following the initiating event. One of the major symptoms of DOMS is muscle pain and stiffness, which can cause inhibition of force production of the involved muscle.

Treatments such as ice, stretching, exercise and massage have been recommended to reduce DOMS, but the research remains unclear on how to best to manage DOMS.

NEJM Article On Ending Breast Cancer Screening Programs Incomplete And Should Concern American Women

The American College of Radiology (ACR) and Society of Breast Imaging (SBI) agree with statements by Andorno and Jüni, in their recent article published in the New England Journal of Medicine (NEJM), that women need clear information with which to discuss mammography with their doctor. 

ACR-logoUnfortunately, the NEJM article failed to meet this standard. The authors minimized the deadly consequences of their recommendations to the Swiss government. The disastrous results may take years to develop. If these guidelines are implemented in this country, they may cost the lives of up to 20,000 American women each year.

The lack of a counterbalancing perspective, in such a major scientific journal, is surprising and concerning. American women should pay close attention to the breast cancer screening policies that may be considered for them.

%d bloggers like this: